Protease-triggered unveiling of bioactive nanoparticles.
作者信息
Harris Todd J, von Maltzahn Geoffrey, Lord Matthew E, Park Ji-Ho, Agrawal Amit, Min Dal-Hee, Sailor Michael J, Bhatia Sangeeta N
机构信息
Harvard-MIT Division of Health Sciences and Technology Massachusetts Institute of Technology E19-502D Cambridge, MA 02139, USA.
出版信息
Small. 2008 Sep;4(9):1307-12. doi: 10.1002/smll.200701319.
Abstract
摘要
相似文献
1
Protease-triggered unveiling of bioactive nanoparticles.
Small. 2008 Sep;4(9):1307-12. doi: 10.1002/smll.200701319.
2
Tumor-targeting and microenvironment-responsive smart nanoparticles for combination therapy of antiangiogenesis and apoptosis.
ACS Nano. 2013 Mar 26;7(3):2860-71. doi: 10.1021/nn400548g. Epub 2013 Mar 12.
3
Enzyme responsive mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo.
Nanoscale. 2015 Feb 28;7(8):3614-26. doi: 10.1039/c5nr00072f.
4
Particle replication in nonwetting templates nanoparticles with tumor selective alkyl silyl ether docetaxel prodrug reduces toxicity.
Nano Lett. 2014 Mar 12;14(3):1472-6. doi: 10.1021/nl4046558. Epub 2014 Feb 24.
5
Preparation of neutron-activatable holmium nanoparticles for the treatment of ovarian cancer metastases.
Small. 2012 Apr 10;8(7):997-1000. doi: 10.1002/smll.201102488. Epub 2012 Feb 2.
6
Investigating the Cellular Specificity in Tumors of a Surface-Converting Nanoparticle by Multimodal Imaging.
Bioconjug Chem. 2017 May 17;28(5):1413-1421. doi: 10.1021/acs.bioconjchem.7b00086. Epub 2017 May 5.
7
Enzyme-responsive multistage vector for drug delivery to tumor tissue.
Pharmacol Res. 2016 Nov;113(Pt A):92-99. doi: 10.1016/j.phrs.2016.08.024. Epub 2016 Aug 19.
8
Tumor-targeting gold particles for dual computed tomography/optical cancer imaging.
Angew Chem Int Ed Engl. 2011 Sep 26;50(40):9348-51. doi: 10.1002/anie.201102892. Epub 2011 Aug 26.
9
Enzyme-Activatable Interferon-Poly(α-amino acid) Conjugates for Tumor Microenvironment Potentiation.
Biomacromolecules. 2019 Aug 12;20(8):3000-3008. doi: 10.1021/acs.biomac.9b00560. Epub 2019 Jul 31.
10
A self-assembled pH/enzyme dual-responsive prodrug with PEG deshielding for multidrug-resistant tumor therapy.
J Mater Chem B. 2020 Feb 14;8(6):1290-1301. doi: 10.1039/c9tb02264c. Epub 2020 Jan 22.
引用本文的文献
1
Quenching of nonlinear photoacoustic signal generation in gold nanoparticles through coating.
Nanoscale Adv. 2020 Jun 18;2(7):2699-2704. doi: 10.1039/d0na00205d. eCollection 2020 Jul 14.
2
Reactive Oxygen Species (ROS) Activated Liposomal Cell Delivery using a Boronate-Caged Guanidine Lipid.
Chemistry. 2022 Aug 16;28(46):e202201057. doi: 10.1002/chem.202201057. Epub 2022 Jun 27.
3
Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery.
Expert Opin Drug Deliv. 2021 Feb;18(2):205-227. doi: 10.1080/17425247.2021.1828339. Epub 2020 Oct 8.
4
Stimuli-Responsive Biomaterials for Vaccines and Immunotherapeutic Applications.
Adv Ther (Weinh). 2020 Nov;3(11):2000129. doi: 10.1002/adtp.202000129. Epub 2020 Aug 2.
5
Developing Nanoceria-Based pH-Dependent Cancer-Directed Drug Delivery System for Retinoblastoma.
Adv Funct Mater. 2018 Dec 27;28(52). doi: 10.1002/adfm.201806248. Epub 2018 Nov 12.
6
Activity-Based Diagnostics: An Emerging Paradigm for Disease Detection and Monitoring.
Trends Mol Med. 2020 May;26(5):450-468. doi: 10.1016/j.molmed.2020.01.013. Epub 2020 Apr 5.
7
Genetic Encoding of Targeted Magnetic Resonance Imaging Contrast Agents for Tumor Imaging.
ACS Synth Biol. 2020 Feb 21;9(2):392-401. doi: 10.1021/acssynbio.9b00416. Epub 2020 Jan 22.
8
Clinical Cancer Nanomedicine.
Nano Today. 2019 Apr;25:85-98. doi: 10.1016/j.nantod.2019.02.005. Epub 2019 Mar 6.
9
Activated Charge-Reversal Polymeric Nano-System: The Promising Strategy in Drug Delivery for Cancer Therapy.
Polymers (Basel). 2016 Apr 5;8(4):99. doi: 10.3390/polym8040099.
10
Cell penetrating peptides in preclinical and clinical cancer diagnosis and therapy.
Oncotarget. 2018 Dec 14;9(98):37252-37267. doi: 10.18632/oncotarget.26442.
本文引用的文献
1
"Smart" drug carriers: PEGylated TATp-modified pH-sensitive liposomes.
J Liposome Res. 2007;17(3-4):197-203. doi: 10.1080/08982100701525035.
2
Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging.
Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15549-54. doi: 10.1073/pnas.0707461104. Epub 2007 Sep 17.
3
Nanoparticle self-assembly gated by logical proteolytic triggers.
J Am Chem Soc. 2007 May 16;129(19):6064-5. doi: 10.1021/ja070461l. Epub 2007 Apr 21.
4
Multifunctional nanocarriers.
Adv Drug Deliv Rev. 2006 Dec 1;58(14):1532-55. doi: 10.1016/j.addr.2006.09.009. Epub 2006 Sep 28.
5
Protease-modulated cellular uptake of quantum dots.
Nano Lett. 2006 Sep;6(9):1988-92. doi: 10.1021/nl0611586.
6
Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid.
Gene Ther. 2007 Jan;14(1):68-77. doi: 10.1038/sj.gt.3302843. Epub 2006 Aug 17.
7
Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models.
Cancer Res. 2006 Jul 1;66(13):6732-40. doi: 10.1158/0008-5472.CAN-05-4199.
8
Proteolytic actuation of nanoparticle self-assembly.
Angew Chem Int Ed Engl. 2006 May 5;45(19):3161-5. doi: 10.1002/anie.200600259.
9
Super pH-sensitive multifunctional polymeric micelle.
Nano Lett. 2005 Feb;5(2):325-9. doi: 10.1021/nl0479987.
10
Tumor imaging by means of proteolytic activation of cell-penetrating peptides.
Proc Natl Acad Sci U S A. 2004 Dec 21;101(51):17867-72. doi: 10.1073/pnas.0408191101. Epub 2004 Dec 15.
Zotero 插件